US Stock MarketDetailed Quotes

NRBO NeuroBo Pharmaceuticals

Watchlist
  • 4.0900
  • -0.2500-5.76%
Close Mar 28 16:00 ET
  • 4.1000
  • +0.0100+0.24%
Post 18:58 ET
20.07MMarket Cap0.11P/E (TTM)

NeuroBo Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
25.42%3.89M
18.24%3.81M
-12.35%2.52M
-25.36%11.42M
-51.51%2.22M
-10.39%3.1M
-18.01%3.22M
-13.66%2.88M
-48.52%15.3M
-76.54%4.58M
Selling and administrative expenses
-36.79%1.6M
-35.54%1.44M
-3.68%1.88M
-1.28%8.64M
-25.80%1.92M
22.37%2.53M
16.88%2.24M
-10.61%1.96M
11.55%8.75M
48.68%2.58M
-General and administrative expense
-36.79%1.6M
-35.54%1.44M
-3.68%1.88M
-1.28%8.64M
-25.80%1.92M
22.37%2.53M
16.88%2.24M
-10.61%1.96M
11.55%8.75M
48.68%2.58M
Research and development costs
301.40%2.29M
140.73%2.36M
-30.76%637K
-57.56%2.78M
-84.73%305K
-59.04%571K
-51.19%982K
-19.51%920K
-70.07%6.55M
-88.77%2M
Operating profit
-25.42%-3.89M
-18.24%-3.81M
12.35%-2.52M
25.36%-11.42M
51.51%-2.22M
10.39%-3.1M
18.01%-3.22M
13.66%-2.88M
48.52%-15.3M
76.54%-4.58M
Net non-operating interest income expense
162K
-15,750.00%-2.19M
-2.19M
0
-64.10%14K
0
Non-operating interest income
--162K
----
----
--0
--0
--0
----
----
-64.10%14K
--0
Non-operating interest expense
----
----
----
--2.19M
----
----
----
----
--0
----
Other net income (expense)
-866.67%-87K
3,757.14%3.07M
-84K
-358K
-265K
-9K
-84K
Gain on sale of security
---87K
--3.07M
---84K
--7.94M
----
----
----
----
----
----
Special income (charges)
----
----
----
---8.21M
----
----
----
----
--0
----
-Less:Other special charges
----
----
----
--8.21M
----
----
----
----
----
----
Other non- operating income (expenses)
----
----
----
---83K
--10K
---9K
---84K
----
----
----
Income before tax
-22.65%-3.82M
77.78%-734K
9.43%-2.6M
8.62%-13.97M
-2.14%-4.68M
10.05%-3.11M
15.76%-3.3M
13.51%-2.88M
48.50%-15.28M
76.54%-4.58M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-22.65%-3.82M
77.78%-734K
9.43%-2.6M
8.62%-13.97M
-2.14%-4.68M
10.05%-3.11M
15.76%-3.3M
13.51%-2.88M
48.50%-15.28M
76.54%-4.58M
Net income continuous Operations
-22.65%-3.82M
77.78%-734K
9.43%-2.6M
8.62%-13.97M
-2.14%-4.68M
10.05%-3.11M
15.76%-3.3M
13.51%-2.88M
48.50%-15.28M
76.54%-4.58M
Minority interest income
Net income attributable to the parent company
-22.65%-3.82M
77.78%-734K
9.43%-2.6M
8.62%-13.97M
-2.14%-4.68M
10.05%-3.11M
15.76%-3.3M
13.51%-2.88M
48.50%-15.28M
76.54%-4.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-22.65%-3.82M
77.78%-734K
9.43%-2.6M
8.62%-13.97M
-2.14%-4.68M
10.05%-3.11M
15.76%-3.3M
13.51%-2.88M
48.50%-15.28M
76.54%-4.58M
Basic earnings per share
97.43%-0.72
99.46%-0.16
98.15%-0.48
20.51%-125.976
-1.28%-42.376
24.89%-28
31.11%-29.76
28.00%-25.92
63.92%-158.48
85.47%-41.84
Diluted earnings per share
97.43%-0.72
99.46%-0.16
98.15%-0.48
20.51%-125.976
-1.28%-42.376
24.89%-28
31.11%-29.76
28.00%-25.92
63.92%-158.48
85.47%-41.84
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 25.42%3.89M18.24%3.81M-12.35%2.52M-25.36%11.42M-51.51%2.22M-10.39%3.1M-18.01%3.22M-13.66%2.88M-48.52%15.3M-76.54%4.58M
Selling and administrative expenses -36.79%1.6M-35.54%1.44M-3.68%1.88M-1.28%8.64M-25.80%1.92M22.37%2.53M16.88%2.24M-10.61%1.96M11.55%8.75M48.68%2.58M
-General and administrative expense -36.79%1.6M-35.54%1.44M-3.68%1.88M-1.28%8.64M-25.80%1.92M22.37%2.53M16.88%2.24M-10.61%1.96M11.55%8.75M48.68%2.58M
Research and development costs 301.40%2.29M140.73%2.36M-30.76%637K-57.56%2.78M-84.73%305K-59.04%571K-51.19%982K-19.51%920K-70.07%6.55M-88.77%2M
Operating profit -25.42%-3.89M-18.24%-3.81M12.35%-2.52M25.36%-11.42M51.51%-2.22M10.39%-3.1M18.01%-3.22M13.66%-2.88M48.52%-15.3M76.54%-4.58M
Net non-operating interest income expense 162K-15,750.00%-2.19M-2.19M0-64.10%14K0
Non-operating interest income --162K----------0--0--0---------64.10%14K--0
Non-operating interest expense --------------2.19M------------------0----
Other net income (expense) -866.67%-87K3,757.14%3.07M-84K-358K-265K-9K-84K
Gain on sale of security ---87K--3.07M---84K--7.94M------------------------
Special income (charges) ---------------8.21M------------------0----
-Less:Other special charges --------------8.21M------------------------
Other non- operating income (expenses) ---------------83K--10K---9K---84K------------
Income before tax -22.65%-3.82M77.78%-734K9.43%-2.6M8.62%-13.97M-2.14%-4.68M10.05%-3.11M15.76%-3.3M13.51%-2.88M48.50%-15.28M76.54%-4.58M
Income tax 0000000000
Net income -22.65%-3.82M77.78%-734K9.43%-2.6M8.62%-13.97M-2.14%-4.68M10.05%-3.11M15.76%-3.3M13.51%-2.88M48.50%-15.28M76.54%-4.58M
Net income continuous Operations -22.65%-3.82M77.78%-734K9.43%-2.6M8.62%-13.97M-2.14%-4.68M10.05%-3.11M15.76%-3.3M13.51%-2.88M48.50%-15.28M76.54%-4.58M
Minority interest income
Net income attributable to the parent company -22.65%-3.82M77.78%-734K9.43%-2.6M8.62%-13.97M-2.14%-4.68M10.05%-3.11M15.76%-3.3M13.51%-2.88M48.50%-15.28M76.54%-4.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -22.65%-3.82M77.78%-734K9.43%-2.6M8.62%-13.97M-2.14%-4.68M10.05%-3.11M15.76%-3.3M13.51%-2.88M48.50%-15.28M76.54%-4.58M
Basic earnings per share 97.43%-0.7299.46%-0.1698.15%-0.4820.51%-125.976-1.28%-42.37624.89%-2831.11%-29.7628.00%-25.9263.92%-158.4885.47%-41.84
Diluted earnings per share 97.43%-0.7299.46%-0.1698.15%-0.4820.51%-125.976-1.28%-42.37624.89%-2831.11%-29.7628.00%-25.9263.92%-158.4885.47%-41.84
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg